The South African National AIDS Council (SANAC) has issued an urgent call for the establishment of secure medical supply chains and the enhancement of local manufacturing capacity. They warn that medicine stockouts and diagnostic delays are costing lives and undermining efforts to end the tuberculosis (TB) epidemic. This critical demand was made during the official relaunch of the South African…
Tag: TB
-
TB Deaths in South Africa Persist Despite Drop in Infections
Tuberculosis (TB) remains South Africa’s most lethal infectious disease. TB deaths claimed an estimated 56,000 lives in 2023. This occurred even as the number of new infections saw a sharp decline, health officials have revealed. The stark figures highlight a growing paradox in the country’s fight against the disease. Although fewer people are contracting TB, a stubbornly high number are…
-
HIV deaths in SA may be four times higher than reported
Concerns over the accuracy of South Africa’s official mortality statistics have been amplified by a recent South African Medical Research Council (SAMRC) study. The study highlights the need to revisit HIV deaths in SA. This is given the potential discrepancies in reported data. The research suggests a dramatic undercounting of HIV-related deaths. These may be potentially four times higher than…
-
Casual contact drives TB spread more than household exposure
A groundbreaking study conducted in KwaZulu-Natal suggests that casual community contact, rather than close household exposure, may be the primary driver of tuberculosis (TB) transmission. Findings from the CONTEXT study indicate that casual contact accounted for 49% of transmission links. In comparison, researchers linked only 9% of cases to the close contact traditionally blamed for spreading the disease. Prof Neel…
-
Research faces funding crisis after NIH grant cuts
South African HIV/AIDS researchers are grappling with the harsh reality of substantial grant funding cuts from the US National Institutes of Health (NIH). These cuts, resulting from a shift in NIH priorities, threaten to derail decades of progress in combating HIV/AIDS and tuberculosis (TB) in a region central to global health efforts. The extent of the terminations and holds on…
-
Competition Commission and J&J reach TB drug agreement
The Competition Commission has reached a landmark agreement with Johnson & Johnson (J&J) and its subsidiary, Janssen Pharmaceuticals, under which J&J will not enforce its patent on a crucial tuberculosis (TB) drug in 134 low- and middle-income countries. Additionally, J&J will reduce the drug’s price for South Africa’s Department of Health by approximately 40%. This decision not to enforce the…